Focus
Gilead Sciences
Class-Action Lawsuit Filed Against Remdesivir Manufacturer Over Alleged Deceptive Practices
Gilead is accused of ‘downplaying or omitting altogether the clinical dangers experienced by patients from remdesivir use.’
Remdesivir Therapy Has ‘Little Effect’ on COVID-19 Mortality: WHO Study
Remdesivir therapy, an experimental antiviral therapy that has been used to treat COVID-19, has no substantial effect on a patient’s chances of survival.
